Table 1 Baseline characteristics of 619 patients with chronic hepatitis C
From: Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients
Factors | n = 619 |
|---|---|
Gender (M/F) | 314/305 |
Age (y.o) | 63 (18–89) |
Body weight (kg) | 59.8 (33.0–115.8) |
BMI (kg/m2) | 23.86 (15.48–37.81) |
Fib-4 Index | 3.12 (0.45–15.97) |
Season (Month) (11-4/5-10/NA) | 361/257/1 |
Leukocytes (/mm3) | 4700 (1800–16,100) |
Hemoglobin (g/dL) | 13.7 (7.5–17.7) |
Platelets (×103/mm3) | 151 (31–407) |
AST (U/L) | 48 (13–398) |
ALT (U/L) | 48 (10–362) |
gamma-GT (U/L) | 43 (8–1031) |
Alpha-fetoprotein (ng/mL) | 5.7 (3.6–754.7) |
Total bilirubin (mg/dL) | 0.7 (0.2–2.8) |
Serum albumin (g/dL) | 4.1 (2.5–5.1) |
Total-cholesterol (mg/dL) | 166 (55–310) |
LDL-cholesterol (mg/dL) | 94 (21–204) |
HDL-cholesterol (mg/dL) | 51 (8–149) |
Serum creatinine (mg/dL) | 0.70 (0.32–11.87) |
HCV RNA (logIU/mL) | 6.4 (1.2–7.8) |
Fasting plasma glucose (mg/dL) | 102 (65–342) |
HOMA-R | 2.0 (0.3–84.7) |
25-hydroxyvitamin D3 (ng/ml) | 21 (6–61) |
Prothrombin time (%) | 90.7 (14.5–177.6) |
ISDR (0,1/others/NA) | 349/158/112 |
Core amino acid 70 (wild type/mutant type/NA) | 291/217/111 |
IL28B genotype rs8099917 (TT/non-TT/NA) | 356/242/21 |
Hepatocellular carcinoma (presence/absence) | 44/575 |